Home › Cancro al fegato (carcinoma epatocellulare) › Alabama › Birmingham
Studi clinici su Cancro al fegato (carcinoma epatocellulare) a Birmingham, AL
8 studi su Cancro al fegato (carcinoma epatocellulare) cercano partecipanti presso sedi a Birmingham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
In reclutamentoFase 1/2
- Research Facility, Birmingham
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- University of Alabama At Birmingham Hospital, Birmingham
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
In reclutamentoFase 1/2
- University of Alabama at Birmingham, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- Children's Hospital of Alabama, Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
In reclutamentoFase 1
- University of Alabama at Birmingham, Birmingham
- University of Alabama at Birmingham, IDS Pharmacy, Birmingham
- University of Alabama at Birmingham, Birmingham
- e altri 1
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
In reclutamento
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
In reclutamentoFase 1/2
- The Kirklin Clinic of University of Alabama Birmingham Hospital, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Birmingham
Studi su Cancro al fegato (carcinoma epatocellulare) in altre città
- Houston, TX31 studi
- New York City, NY24 studi
- Dallas, TX19 studi
- Los Angeles, CA19 studi
- Boston, MA18 studi
- Cleveland, OH18 studi
- Chicago, IL16 studi
- Philadelphia, PA16 studi
- Pittsburgh, PA15 studi
- San Francisco, CA14 studi
- Orange, CA14 studi
- Jacksonville, FL14 studi
Altri studi a Birmingham
- Cancro (tutti i tipi)31 studi
- Cancro al seno24 studi
- Cancro ovarico23 studi
- Obesità23 studi
- Cancro del polmone non a piccole cellule22 studi
- Leucemia mieloide acuta21 studi
- Mieloma multiplo18 studi
- BPCO17 studi
- Malattie cardiovascolari17 studi
- Diabete di tipo 216 studi
- Cancro dell'endometrio16 studi
- Sovrappeso16 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.